News

 

 

Funding: New Awards

New Awards

Mary Jo Turk, PhD
Member, Cancer Immunology and Cancer Immunotherapy Research Program at Norris Cotton Cancer Center and Assistant Professor of Microbiology & Immunology at Dartmouth Medical School

  • American Cancer Society Research Scholar Grant
    Tumor-Specific T-cell Memory and the Role of Autoimmunity

Elliott Fisher, MD, MPH
Member, Cancer Control Research Program at Norris Cotton Cancer Center and Professor of Medicine and of Community & Family Medicine at Dartmouth Medical School

  • The Brookings Institution
    Chronic Care Improvement with Effective Health Information Technology

Anna Tosteson, ScD
Member, Cancer Control Research Program at Norris Cotton Cancer Center and Professor of Community & Family Medicine at Dartmouth Medical School

  • DHHS
    Advancing Systems Approaches to Personal and Population Breast Cancer Screening
New Clinical Trials

Konstantin Dragnev, MD
Member, Cancer Epidemiology and Chemoprevention Research Program at Norris Cotton Cancer Center, and Associate Professor of Medicine and of Pharmacology & Toxicology at Dartmouth Medical School

  • Celgene Corporation
    An open-label randomized, Phase 2A, dose-ranging study (Part 1) of sotatercept (ACE-011) for chemotherapy-induced anemia in subjects with selected metastatic solid tumors treated with platinum-based chemotherapeutic regimens followed by a Phase 2B/3, double-blind, randomized, placebo-controlled study (Part 2) of sotatercept (ACE-011) for chemotherapy-induced anemia in subjects with metastatic non small cell lung cancer treated with first-line platinum-based chemotherapeutic regimen

Marc Ernstoff, MD
Member, Immunology and Cancer Immunotherapy Research Program at Norris Cotton Cancer Center and Professor of Medicine at Dartmouth Medical School

  • Hoffman La Roche
    A Phase I, randomized, open-label, multi-center, two period crossover study to investigate the effect of food on the pharmacokinetics of a single oral dose of RO5185426, followed by administration of 960 mb RO5185426 twice daily to BRAFV600E positive metastatic melanoma patients

Frederick Lansigan, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center and Assistant Professor of Medicine at Dartmouth Medical School

  • PI/Department Funding
    Outcomes of patients with newly diagnosed peripheral t-cell lymphoma treated with aggressive chemotherapy

Lionel Lewis, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center and Professor of Medicine and of Pharmacology & Toxicology at Dartmouth Medical School

  • Abbott Laboratories
    A Phase 1, open-label, randomized, adaptive, cross-over study evaluating the bioavailability of two formulations of linifanib and food effect on pharmacokinetics of linifanib in subjects with advanced or metastatic solid tumors (M12-468)
  • GlaxoSmithKline Group
    A Phase IV, placebo-controlled single sequence crossover study to evaluate the effect of repeat oral doses of lapatinib on cardiac repolarization in patients with advanced cancer